Accelera Innovations, Inc (ACNV)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2016 | 2015 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | -214.81 Thousand | -29.21 Thousand |
| Net Income | - | - | - | - | -1.92 Million | -14.92 Million |
| Depreciation & Amortization | - | - | - | - | 2000.00 | 1259.00 |
| Deferred income taxes | - | - | - | - | - | 15.43 Thousand |
| Stock-based compensation | - | - | - | - | 1616.14 | 7.73 Million |
| Change in working capital | - | - | - | - | 98.2 Thousand | 1.16 Million |
| Other non-cash items | - | - | - | - | 1.61 Million | 5.97 Million |
| Investing Cash Flow | - | - | - | - | - | -3767.00 |
| Investments in PPE | - | - | - | - | - | -3767.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | 214.81 Thousand | 452.68 Thousand |
| Debt repayment | - | - | - | - | -21.97 Thousand | -74.3 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 15 Thousand |
| Other Financing Activities | - | - | - | - | 236.79 Thousand | 511.98 Thousand |
| Accounts receivables | - | - | - | - | -2750.00 | 605.79 Thousand |
| Accounts payables | - | - | - | - | 56.46 Thousand | 385.82 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | 44.49 Thousand | 176.94 Thousand |
| Cash at beginning of period | - | - | - | - | - | 54.86 Thousand |
| Cash at end of period | - | - | - | - | - | 474.56 Thousand |
| Capital Expenditure | - | - | - | - | - | -3767.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | - | 419.7 Thousand |
| Free Cash Flow | - | - | - | - | -214.81 Thousand | -32.98 Thousand |
| Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2017 Q3 | 2017 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | - | -16.45 Thousand | -47.35 Thousand |
| Depreciation & Amortization | - | - | - | - | 500.00 | 500.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | 7.50 | 7.50 |
| Change in working capital | - | - | - | - | -16.8 Thousand | -5224.00 |
| Other non-cash items | - | - | - | - | 2009.00 | 19.58 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | 30.75 Thousand | 32.5 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 30.75 Thousand | 32.50 |
| Accounts receivables | - | - | - | - | - | 2.75 |
| Accounts payables | - | - | - | - | -5413.00 | 18.42 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | -11.38 Thousand | -23.64 Thousand |
| Cash at beginning of period | - | - | - | - | - | - |
| Cash at end of period | - | - | - | - | - | - |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | -30.75 Thousand | -32.5 Thousand |
1053
601898
ARTO
GRCM
TALLINK
194480